No abstract

Pelvic exenteration (PE) is a radical procedure involving the resection of multiple pelvic viscera for primary and recurrent pelvic malignancies. The median 5-year overall survival for those with locally advanced and locally recurrent rectal cancers undergoing PE has been reported at 38% and 28%, respectively [1,2], and for gynaecological cancers it is 40% [3]. In the case of colorectal cancer, this compares with a 5-year survival of <5% without resection [4].

No abstract